Ladenburg Thalmann Financial Services’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $25K | Buy |
405
+98
| +32% | +$6.05K | ﹤0.01% | 3997 |
|
|
2019
Q3 | $22K | Sell |
307
-219
| -42% | -$15.7K | ﹤0.01% | 3974 |
|
|
2019
Q2 | $44K | Sell |
526
-119
| -18% | -$9.95K | ﹤0.01% | 3536 |
|
|
2019
Q1 | $45K | Sell |
645
-78
| -11% | -$5.44K | ﹤0.01% | 3468 |
|
|
2018
Q4 | $34K | Buy |
723
+282
| +64% | +$13.3K | ﹤0.01% | 3518 |
|
|
2018
Q3 | $24K | Sell |
441
-790
| -64% | -$43K | ﹤0.01% | 3791 |
|
|
2018
Q2 | $72K | Hold |
1,231
| – | – | ﹤0.01% | 2993 |
|
|
2018
Q1 | $72K | Sell |
1,231
-3
| -0.2% | -$175 | ﹤0.01% | 2993 |
|
|
2017
Q4 | $80K | Buy |
1,234
+30
| +2% | +$1.95K | ﹤0.01% | 2878 |
|
|
2017
Q3 | $63K | Sell |
1,204
-57
| -5% | -$2.98K | ﹤0.01% | 2932 |
|
|
2017
Q2 | $59K | Buy |
1,261
+98
| +8% | +$4.59K | ﹤0.01% | 2907 |
|
|
2017
Q1 | $57K | Buy |
1,163
+463
| +66% | +$22.7K | ﹤0.01% | 2815 |
|
|
2016
Q4 | $42K | Buy |
700
+89
| +15% | +$5.34K | ﹤0.01% | 2963 |
|
|
2016
Q3 | $41K | Buy |
611
+309
| +102% | +$20.7K | ﹤0.01% | 2926 |
|
|
2016
Q2 | $17K | Sell |
302
-7
| -2% | -$394 | ﹤0.01% | 3435 |
|
|
2016
Q1 | $10K | Hold |
309
| – | – | ﹤0.01% | 3687 |
|
|
2015
Q4 | $14K | Buy |
309
+187
| +153% | +$8.47K | ﹤0.01% | 3458 |
|
|
2015
Q3 | $5K | Buy |
122
+13
| +12% | +$533 | ﹤0.01% | 3907 |
|
|
2015
Q2 | $6K | Sell |
109
-300
| -73% | -$16.5K | ﹤0.01% | 3952 |
|
|
2015
Q1 | $25K | Buy |
+409
| New | +$25K | ﹤0.01% | 3039 |
|
|
2014
Q3 | – | Sell |
-250
| Closed | -$9K | – | 3912 |
|
|
2014
Q2 | $9K | Sell |
250
-150
| -38% | -$5.4K | ﹤0.01% | 3117 |
|
|
2014
Q1 | $13K | Buy |
400
+192
| +92% | +$6.24K | ﹤0.01% | 2804 |
|
|
2013
Q4 | $4K | Sell |
208
-7
| -3% | -$135 | ﹤0.01% | 3305 |
|
|
2013
Q3 | $2K | Sell |
215
-1
| -0.5% | -$9 | ﹤0.01% | 3421 |
|
|
2013
Q2 | $1K | Buy |
+216
| New | +$1K | ﹤0.01% | 3429 |
|